scholarly journals LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes

Diabetologia ◽  
2015 ◽  
Vol 59 (3) ◽  
pp. 634-643 ◽  
Author(s):  
Megan V. Cannon ◽  
Herman H. W. Silljé ◽  
Jürgen W. A. Sijbesma ◽  
Mohsin A. F. Khan ◽  
Knut R. Steffensen ◽  
...  

2017 ◽  
Vol 31 (7) ◽  
pp. 3138-3149 ◽  
Author(s):  
Giovanna Sociali ◽  
Mirko Magnone ◽  
Silvia Ravera ◽  
Patrizia Damonte ◽  
Tiziana Vigliarolo ◽  
...  


2020 ◽  
Vol 45 (10) ◽  
pp. 1127-1137 ◽  
Author(s):  
Dengqiu Xu ◽  
Xiaofei Huang ◽  
Hozeifa M. Hassan ◽  
Lu Wang ◽  
Sijia Li ◽  
...  

Type 2 diabetes mellitus is a major health problem and a societal burden. Individuals with prediabetes are at increased risk of type 2 diabetes mellitus. Catalpol, an iridoid glycoside, has been reported to exert a hypoglycaemic effect in db/db mice, but its effect on the progression of prediabetes is unclear. In this study, we established a mouse model of prediabetes and examined the hypoglycaemic effect, and the mechanism of any such effect, of catalpol. Catalpol (200 mg/(kg·day)) had no effect on glucose tolerance or the serum lipid level in a mouse model of impaired glucose tolerance-stage prediabetes. However, catalpol (200 mg/(kg·day)) increased insulin sensitivity and decreased the fasting glucose level in a mouse model of impaired fasting glucose/impaired glucose tolerance-stage prediabetes. Moreover, catalpol increased the mitochondrial membrane potential (1.52-fold) and adenosine triphosphate content (1.87-fold) in skeletal muscle and improved skeletal muscle function. These effects were mediated by activation of the insulin receptor-1/glucose transporter type 4 (IRS-1/GLUT4) signalling pathway in skeletal muscle. Our findings will facilitate the development of a novel approach to suppressing the progression of diabetes at an early stage. Novelty Catalpol prevents the progression of prediabetes in a mouse model of prediabetes. Catalpol improves insulin sensitivity in skeletal muscle. The effects of catalpol are mediated by activation of the IRS-1/GLUT4 signalling pathway.





2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Lixia He

Abstract Objectives Type 2 diabetes mellitus (T2DM) ranks highly on the international health agenda as a global pandemic and as a threat to human health and global economies. Effective preventive strategies are urgently needed. This study was conducted to investigate the effects of cow milk and goat milk on glucose management in high fat-induced obesity (DIO) mice and db/db mice. Methods In the DIO mouse model, male C57BL/6 mice were randomly assigned into one the following experimental groups and fed the corresponding diet for 16 weeks: negative control (10% caloric fat), high fat control (60% caloric fat), cow milk (high fat with 20% cow milk powder replacing dietary protein), or goat milk (high fat with 20% goat milk powder replacing dietary protein). In the db/db mouse model, female db/db mice were randomly assigned into one of the following experimental groups and consume corresponding AIN-93 M based diets: control (AIN-93 M diet), cow milk (20% cow milk replacing dietary protein), or goat milk (20% cow milk replacing dietary protein); Conventional C57BL mice were used as the negative control. The glucose tolerance test was conducted at different time points. At the end of the experiments, mice were sacrificed, blood samples were collected for measurement of glucose, insulin, HbA1c and glucagon levels, pancreases were collected for histological and immunohistochemical evaluation, and muscles were collected for RT-PCR analysis. Results In the DIO model, both cow milk and goat milk significantly decreased fasting blood glucose (FBG) levels after 14 and 16 weeks of treatment without significant effects on body weight. Goat milk, but not cow milk, significantly reduced serum insulin level. In the db/db model, both cow milk and goat milk significantly decreased FBG and glucose tolerance after 6 weeks of treatment. Goat milk also improved blood levels of insulin, HbA1c and glucagon. Both cow milk and goat milk also improved histopathological damages and markedly up-regulated the expressions of phosphatidylinositol-3-kinase (PI-3 K), protein kinase B (Akt), glucose transporters-4 (GLUT4) mRNA involved in the PI-3 K/Akt signaling pathway of T2DM. Conclusions Our results suggest that dietary intake of cow milk and especially goat milk may significantly improve glucose tolerance, thus may delay the development and progression of type 2 diabetes. Funding Sources Feihe Nutrition Laboratory Funds.



Diabetes ◽  
2006 ◽  
Vol 55 (2) ◽  
pp. 367-374 ◽  
Author(s):  
K. Y. Chu ◽  
T. Lau ◽  
P.-O. Carlsson ◽  
P. S. Leung




2014 ◽  
Author(s):  
Silvia Pabisch ◽  
Tsuguno Yamaguchi ◽  
Yasushi Koike ◽  
Kenji Egashira ◽  
Shinsuke Kataoka ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document